We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$988M
(+10%)
Cap. Flow
+$812M
Cap. Flow
% of AUM
7.54%
Top 10 Holdings %
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$32.7M |
| 2 |
Eli Lilly
LLY
|
+$31M |
| 3 |
La-Z-Boy
LZB
|
+$17.4M |
| 4 |
Ubiquiti
UI
|
+$17.1M |
| 5 |
TriMas Corp
TRS
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LSB Industries
LXU
|
+$14M |
| 2 |
K
Kellanova
K
|
+$13.7M |
| 3 |
Apple
AAPL
|
+$13.1M |
| 4 |
Prosperity Bancshares
PB
|
+$11.7M |
| 5 |
Fluor
FLR
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.72% |
| 2 | Industrials | 12.7% |
| 3 | Healthcare | 12.22% |
| 4 | Financials | 10.93% |
| 5 | Energy | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRDX
951
DELISTED
Surmodics
SRDX
| $326K | ﹤0.01% |
14,456
| – | – |
|
952
Matsons
MATX
$6.22B
| $325K | ﹤0.01% |
13,187
-70
| -0.5% | -$1.73K |
|
953
Invesco BuyBack Achievers ETF
PKW
$1.71B
| $325K | ﹤0.01% |
+7,495
| New | +$319K |
|
|
BPL
954
DELISTED
Buckeye Partners, L.P.
BPL
| $325K | ﹤0.01% |
4,334
| – | – |
|
|
STRZA
955
DELISTED
Starz - Series A
STRZA
| $325K | ﹤0.01% |
10,111
-140
| -1% | -$4.25K |
|
956
AGCO
AGCO
$8.71B
| $322K | ﹤0.01% |
5,867
-140,937
| -96% | -$7.54M |
|
957
Roper Technologies
ROP
$37.1B
| $320K | ﹤0.01% |
2,404
-100
| -4% | -$13.6K |
|
958
State Street SPDR Dow Jones International Real Estate ETF
RWX
$265M
| $320K | ﹤0.01% |
7,781
-35
| -0.4% | -$1.42K |
|
959
Xylem
XYL
$28.6B
| $320K | ﹤0.01% |
8,795
-487
| -5% | -$17.8K |
|
960
Comfort Systems
FIX
$60.9B
| $319K | ﹤0.01% |
+20,980
| New | +$358K |
|
|
RFMD
961
DELISTED
RF MICRO DEVICES INC
RFMD
| $318K | ﹤0.01% |
40,430
+39,623
| +4,910% | +$244K |
|
|
DSPG
962
DELISTED
DSP Group Inc
DSPG
| $317K | ﹤0.01% |
36,691
+682
| +2% | +$6.19K |
|
|
TYC
963
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $316K | ﹤0.01% |
7,153
-349
| -5% | -$15.2K |
|
|
PEI
964
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $314K | ﹤0.01% |
1,162
-27
| -2% | -$7.52K |
|
|
GLF
965
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
| $314K | ﹤0.01% |
6,998
| – | – |
|
966
Ambev
ABEV
$47.4B
| $312K | ﹤0.01% |
42,230
+11,430
| +37% | +$80K |
|
967
CONMED
CNMD
$1.31B
| $312K | ﹤0.01% |
7,195
| – | – |
|
968
Morningstar
MORN
$6.94B
| $311K | ﹤0.01% |
3,947
+3
| +0.1% | +$239 |
|
969
Teekay Tankers
TNK
$2.63B
| $311K | ﹤0.01% |
11,006
-10,123
| -48% | -$317K |
|
|
FISV
970
Fiserv Inc
FISV
$27.9B
| $309K | ﹤0.01% |
10,920
| – | – |
|
971
Manhattan Associates
MANH
$9.42B
| $309K | ﹤0.01% |
8,848
-1,664
| -16% | -$57.9K |
|
972
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
| $309K | ﹤0.01% |
9,099
-300
| -3% | -$9.88K |
|
|
SYT
973
DELISTED
Syngenta Ag
SYT
| $306K | ﹤0.01% |
4,046
-13,409
| -77% | -$998K |
|
974
Goodyear
GT
$2.04B
| $305K | ﹤0.01% |
11,678
-2,055
| -15% | -$52.3K |
|
975
Interparfums
IPAR
$3.99B
| $305K | ﹤0.01% |
+8,440
| New | +$284K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2014 Portfolio in Review
As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.
- Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
- Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
- Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
- Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
- Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
- Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
- Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.
Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.